↓ Skip to main content

Fibroblast growth factor-23 and the risk of cardiovascular diseases and mortality in the general population: A systematic review and dose-response meta-analysis

Overview of attention for article published in Frontiers in Cardiovascular Medicine, November 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
20 Mendeley